For last week’s practice question, we quizzed participants on Triglyceride Management. 63% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
JT is 58-years-old and has type 2 diabetes, hypertension, and BMI is 32 kg/m². Medications include metformin, lisinopril, and atorvastatin. Diet intake includes frequent highly processed foods, sugary beverages, no alcohol consumption, and minimal physical activity. Recent lab work indicates A1c: 7.2%, LDL:82 mg/dL, HDL: 38 mg/dL, triglycerides: 345 mg/dL, AST/ALT were both normal.
Given these findings, what is the recommended first-line intervention for managing his elevated triglycerides according to the 2025 ADA Standards of Care?
Answer Choices:
Answer 1 is incorrect. 7.93% chose this answer, “Omega-3 fatty acid.” Icosapent ethyl, a refined omega-3 fatty acid, is typically considered when triglycerides ≥ 500 mg/dL to help lower levels and reduce pancreatitis risk, but they are not typically first-line for triglycerides at 345 mg/dL. For individuals with known cardiovascular risk consideration of additional of Icosapent ethyl could be added after maximizing statin therapy.
Answer 2 is correct. 63% of you chose this answer, “Lifestyle modification (nutrition, physical activity, and weight management.” The first-line recommendation for triglycerides 150-499 mg/dL is lifestyle modification. This may include dietary modifications (types of fats, reducing added sugars, refined carbohydrates, and alcohol), increasing physical activity, and weight loss, if applicable. If triglycerides remain elevated or reach ≥ 500 mg/dL, pharmacologic treatment such as icosapent ethyl or fibrates may be considered to reduce the risk of pancreatitis.
Answer 3 is incorrect. About 10% of respondents chose this, “Start a Statin.” JT is already taking a statin, atorvastatin. Although we can consider maximizing statin therapy as LDL is above 70 mg/dl, this is not the best answer. Statins may have a modest triglyceride-lowering effect, they are not the primary treatment for hypertriglyceridemia at this level.
Finally, Answer 4 is incorrect. 18.41% chose this answer, “Start a Fenofibrate.” Fenofibrate are typically recommended when triglycerides elevate greater than 500 mg/dL to reduce pancreatitis risk and addition could be
considered if lifestyle therapy does not indicate benefit.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
For last week’s practice question, we quizzed participants on best approach: fasting during Ramadan . 74% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question:
JL observes Ramadan and fasts from sunrise to sunset. JL has type 2 diabetes and usually takes 4 units of bolus insulin three times a day with meals and 10 units of glargine (Rezvoglar) at bedtime.
What would be the best recommendation for JL?
Answer Choices:
Answer 1 is incorrect. 3% chose this answer, See if JL can get a note from your doctor to allow eating during the day. With careful planning and insulin adjustments, we can honor JL’s religious fast and cultural beliefs.
Answer 2 is correct. 76% of you chose this answer, Take bolus insulin when JL eats a meal. Yes, this is the BEST answer. If the basal insulin is dosed correctly, it won’t cause hypoglycemia while fasting. JL can hold bolus insulin during fasting, and take bolus insulin when eating.
Answer 3 is incorrect. About 9% of respondents chose this, Monitor urine ketones at least twice a day. There is no need to monitor ketones, since JL will be taking basal insulin daily and bolus insulin with meals, which will prevent ketosis.
Finally, Answer 4 is incorrect. 12% chose this answer, Switch glargine to degludec to decrease risk of hypoglycemia. There is no need to switch basal insulins. JL can stay on glargine, recognizing that it may need to be adjusted.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
For last week’s practice question, we quizzed participants on ADA Standards & what is next med addition? 67% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question:
JR has type 2 diabetes and takes Metformin 1000mg BID and sitagliptin (Januvia), A1C 8.1%. GFR 47, UACR 158mg/g. Recent diagnosis of congestive heart failure. These are the medications their insurance covers.
Of the following medications, which addition would most benefit JR?
Answer Choices:
For a helpful reference, please see our PocketCards for more information.
Answer 1 is incorrect. 5% chose this answer, “Glipizide (Glucotrol)”. Even though glipizide would help lower blood glucose, considering JL’s CHF and worsening kidney function, it is not the best choice.
Answer 2 is incorrect. 8% of you chose this answer, “pioglitazone (Actos)”. Even though pioglitazone would help lower blood glucose, considering JL’s CHF and worsening kidney function, it is not the best choice.
Answer 3 is incorrect. About 18% of respondents chose this, “Semaglutide (Ozempic)”. Even though semaglutide would help lower blood glucose and would address worsening kidney function, considering JL’s CHF and worsening kidney function, it is not the best choice.
Finally, Answer 4 is correct. 67% chose this answer, “Dapagliflozin (Farxiga)”. YES, GREAT JOB. Dapagliflozin is a SGLT-2i that will help lower blood glucose, address worsening kidney function and CHF. Plus, it is covered by insurance. Considering JL’s health profile, it is the best choice.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
For last week’s practice question, we quizzed participants on. 79% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question.
Question:
According to the 2025 ADA Standards of Care, which of the following nutrition behaviors are strongly encouraged for individuals with diabetes?
Answer Choices:
Answer 1 is incorrect. 1.7% chose this answer, ” Incorporate onions, garlic, celery, carrots and other vegetables for a base of homemade foods.” Although this answer is true, it is not the best answer. Incorporate onions, garlic, celery, carrots, and other vegetables for a base of homemade foods. These foods can serve as a base to many dishes and incorporates flavor, fiber, vitamins, and minerals while encouraging vegetable consumption.
Answer 2 is incorrect. 4% of you chose this answer, “Use herbs and spices to season foods instead of salt containing preparations.” Although this answer is true, it is not the best answer. 90% of people in the US exceed the daily recommended limits for sodium. Reducing salt intake is important for heart health, managing blood pressure and meeting dietary guidelines. Herbs and spices not only enhance flavor and may provide additional health benefits.
Answer 3 is incorrect. About 12% of respondents chose this, “Water should be the primary beverage of choice.” Although this answer is true, it is not the best answer. The 2025 ADA Standards of Care have emphasized water as the primary beverage of choice. Alternatives to plain water can include no calorie alternatives. Suggestions to add lemon, lime or cucumber to water, choose sparkling no calorie beverages and no-calorie carbonated beverages are also encouraged.
Answer 4 is incorrect. 2% chose this answer, “Include family or roommate in meal preparation.” Although this answer is true, it is not the best answer. Engaging others in meal preparation can create a supportive environment, encourage healthier eating habits, and make cooking more enjoyable. Social support can be especially helpful in managing diabetes long-term.
Answer 5 is correct. 79% chose this answer, “All of the above.” The 2025 ADA Standards of Care encourages all the above nutrition behaviors.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
For last week’s practice question, we quizzed participants oAction needed to prevent heart failure. 41% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question:
Adults with diabetes are at increased risk for the development of asymptomatic or symptomatic heart failure.
According to the ADA 2025 Standards of care, what action is needed to facilitate prevention of heart failure?
Answer Choices:
Answer 1 is incorrect. 27% chose this juicy answer. “Recommend the DASH Diet.” Although the DASH Diet with lower sodium content is helpful once someone is diagnosed with heart failure, this dietary approach alone won’t prevent heart failure. In order to prevent heart failure, it needs to first be diagnosed to determine best treatment plan.
Answer 2 is correct. 49% of you chose this answer. “Measure natriuretic peptide (BNP or pro-BNP).” YES, Great JOB. According to the ADA Standard on ASCVD, “Adults with diabetes are at increased risk for the development of asymptomatic cardiac structural or functional abnormalities (stage B heart failure) or symptomatic (stage C) heart failure. Consider screening adults with diabetes by measuring a natriuretic peptide (B-type natriuretic peptide [BNP] or N-terminal pro-BNP [NT-proBNP]) to facilitate prevention of stage C heart failure. In asymptomatic individuals with diabetes and abnormal natriuretic peptide levels, echocardiography is recommended to identify stage B heart failure.”
Answer 3 is incorrect. About 11% of respondents chose this. “Assess ankle circumference at each visit.” Although pedal edema and shortness of breath are both indicators of heart failure, the BNP or NT-proBNP lab test is more definitive.
Finally, Answer 4 is incorrect. 18% chose this answer. “Recommend echocardiography after age 55.” According to ADA standards, we would first check the BNP or NT-proBNP lab test. In asymptomatic individuals with diabetes and abnormal natriuretic peptide levels, echocardiography is then recommended to identify stage B heart failure.”
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
For last week’s practice question, we quizzed participants on what defines overbasalization according to 2025 ADA Standards? 60% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question:
According to ADA 2025 Standards, more intensive preventive approaches should be considered in individuals who are at particularly high risk of progression to diabetes, including individuals with BMI ≥35 kg/m2 who:
Answer Choices:
Answer 1 is incorrect. 25% chose this answer, “Sit more than eight hours a day and have a sedentary lifestyle”. Although the ADA Standards recommend getting up and moving every half-hour, they don’t specify that eight hours of sitting a day qualifies a person as higher risk to progressing to diabetes.
Answer 2 is incorrect. 7% of you chose this answer “Have a history of thyroid or celiac disease”. These autoimmune conditions are more closely associated with immune mediated type 1 diabetes and do not place a person as higher risk for progression to type 2 diabetes.
Answer 3 is incorrect. About 9% of respondents chose this, “Consume a diet with high amounts of simple carbohydrates.” While eating foods rich in fiber and a variety of nutrients is important to decrease risk of diabetes, the ADA does not state that eating simple carbohydrates puts individuals in a higher risk category of progressing to diabetes.
Finally, Answer 4 is correct 60% chose this answer, “Have fasting plasma glucose of 110–125 or A1C ≥6.0%.” Great job. This is the BEST answer. According to ADA 2025 Standards, “More intensive preventive approaches should be considered in individuals who are at particularly high risk of progression to diabetes, including individuals with BMI ≥35 kg/m2, those at higher glucose levels (e.g., fasting plasma glucose 110–125 mg/dL [6.1–6.9 mmol/L], 2-h post challenge glucose 173–199 mg/dL [9.6–11.0 mmol/L], and A1C ≥6.0% [≥42 mmol/mol]), and individuals with a history of gestational diabetes mellitus.”
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
For last week’s practice question, we quizzed participants on what defines overbasalization according to 2025 ADA Standards?. 52% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question:
What defines overbasalization according to 2025 ADA Standards?
According to the new 2025 ADA Standards of Care, which of the following most accurately reflects overbasalization?
Answer Choices:
Answer 1 is incorrect. 25% chose this answer: basal insulin doses exceeding 0.5 units/kg/day. This year, the ADA Recommendation was revised to remove consideration of basal insulin doses exceeding 0.5 units/kg/day as evidence of overbasalization. Instead, signs of overbasalization including significant bedtime-to-morning or postprandial-to-preprandial glucose differential, occurrences of hypoglycemia (aware or unaware), and high glycemic variability should be used.
Answer 2 is correct. 52% of you chose this answer: significant bedtime-to-morning or postprandial-to-preprandial glucose differential. GREAT JOB! In the 2025 ADA Standards (9), they define overbasalization as significant bedtime-to-morning or postprandial-to-preprandial glucose differential, occurrences of hypoglycemia (aware or unaware), and high glycemic variability.
Answer 3 is incorrect. About 18% of respondents chose this: low glycemic variability, This is a juicy and tempting answer. However, high glycemic variability (lots of ups and downs) is more closely associated with hypoglycemia.
Finally, Answer 4 is incorrect 3% chose this answer: basal insulin dose exceeding 50 units twice per day. Overbasalization is not defined by the amount of insulin used, but by the glucose response including significant bedtime-to-morning or postprandial-to-preprandial glucose differential, occurrences of hypoglycemia (aware or unaware), and high glycemic variability
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Ready for your certification exams? Our Level 3 course series is the final step in your exam prep, complementing our Level 1, 2, or 4 bundles. Designed for healthcare professionals preparing for diabetes certification exams in 3-6 months, this master-level series covers key topics like pharmacology, technology, MNT, and person-centered care, all based on the latest ADA Standards of Care.
Each course includes a video, podcast, practice test, and additional resources—available immediately for one full year. Boost your knowledge and confidence to succeed in your certification!
For last week’s practice question, we quizzed participants on ADA Standards identify another 1st line med to treat kidney disease. 63.39% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question:
According to the ADA 2025 Standards, new clinical trials suggest that another diabetes medication (besides SGLT-2i) can be used as a first line agent to treat chronic kidney disease.
Which of the folowing diabetes meds is effective as a first-line agent for people with CKD?
Answer Choices:
Answer 1 is incorrect. 2% chose the answer, Afrezza inhaled insulin. Insulin helps lower blood glucose levels, which contributes to improved overall vessel health. However, there are currently no specific studies supporting the use of Afrezza as a first-line treatment strategy for managing chronic kidney disease.
Answer 2 is correct. 63.39% of you chose this answer the best answer, semaglutide (Ozempic). GREAT JOB! According to the 2025 ADA Standards, “a recent clinical trial suggests that the GLP-1 RA semaglutide has a beneficial effect on CVD, mortality, and kidney outcomes among people with Chronic Kidney Disease (CKD), leading to the recommendation that semaglutide can be used as another first-line agent for people with CKD.”
Answer 3 is incorrect. About 12.34% of respondents chose Amylin (Pramlintide). Amylin is an injected hormone mimetic that helps lower blood glucose levels. However, there are currently no specific studies supporting the use of Amylin as a first-line treatment strategy for managing chronic kidney disease.
Finally, Answer 4 is incorrect. 22.38% chose this answer, Sitagliptin (Januvia). Sitagliptin helps lower A1C levels by 0.5-0.7%. However, there are currently no specific studies supporting the use of sitagliptin as a first-line treatment strategy for managing chronic kidney disease.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
This is our most popular course of the year, offering the perfect opportunity to immerse yourself in the essential content featured in this comprehensive 300-page clinical guidebook.
“As always, Bev delivers comprehensive human-centered material to make me a better educator and leader.“- DiabetesEd Student
We hope to see you there!
[yikes-mailchimp form="1"]
Diabetes Education Services offers education and training to diabetes educators in the areas of both Type 1 and Type 2 Diabetes for the novice to the established professional. Whether you are training to be a Certified Diabetes Care and Education Specialist (CDCES), practicing at an advanced level and interested in board certification, or a health care professional and/or Certified Diabetes Care and Education Specialist (CDCES) who needs continuing education hours to renew your license or CDCES, we have diabetes education information, resources and training; learning and teaching tools; and diabetes online courses available for continuing education (CE). Read our disclaimer for full disclosure.